Personalized Substance Control and Delivery Systems

A next-generation system for controlling and delivering substances, utilizing real-time data analytics, AI-powered control units, and modular, wearable, or handheld devices to optimize substance stability, potency, and personalized delivery.

The original patent disclosed devices, systems, and methods for controlling conditions and delivery of substances, addressing the limitations of environmental conditions affecting drug activity. However, these solutions were limited to controlling a few environmental conditions and lacked real-time data analytics, AI-powered control, and modular design. The new inventive concept addresses these limitations by providing a more comprehensive and adaptive approach to substance control and delivery.

The new inventive concept comprises a system of wearable or handheld substance containers with integrated sensors for monitoring user biometrics and environmental conditions, and a control unit for adjusting substance delivery based on real-time data analytics. The system can dynamically adjust storage conditions to optimize substance stability and potency, and features a modular design with interchangeable substance containers and a cloud-based control system for remote monitoring and control. Additionally, the system includes a smart substance delivery device with an AI-powered control unit and a mobile app for personalized dosage recommendations and real-time monitoring of substance efficacy. The decentralized substance management network ensures secure and transparent tracking of substance origin, quality, and movement.

The new inventive concept introduces the use of real-time data analytics, AI-powered control units, and modular design, which are not present in the original patent. The combination of these features provides a more comprehensive and adaptive approach to substance control and delivery, making the original inventive concept obsolete.

Alternative embodiments of the inventive concept could include implantable substance containers, ingestible sensors, or nanotechnology-based substance delivery systems. Variations could also include integrating the system with electronic health records, telemedicine platforms, or artificial intelligence-powered medical diagnosis tools.

The new inventive concept has significant commercial potential in the pharmaceutical, biotechnology, and healthcare industries, particularly in the areas of personalized medicine, precision therapy, and digital health. The system's ability to optimize substance stability, potency, and delivery could lead to improved treatment outcomes, reduced healthcare costs, and enhanced patient experiences.